AnaptysBio (NASDAQ: ANAB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AnaptysBio (NASDAQ: ANAB) through any online brokerage.
The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Guggenheim on Tuesday, March 22, 2022. The analyst firm set a price target for 0.00 expecting ANAB to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for AnaptysBio (NASDAQ: ANAB) is $24.69 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for AnaptysBio.
AnaptysBio’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.